Bad Economics But Good Medicine

Ocean County Observer

March 17, 1980

 

 

 

Medical World News editorially applauded Dr. Marvin Moser for taking to task hospitals that grew “fat” with excess instrumentation, house staff, and costly technology that does nothing more than increase hospital and physician income.

 

This of course is a touchy subject to all concerned. To the taxpayer part of whose annual donation to the IRS is devoted to medical payments; and to the sick that are subject to the “excess testing” that Dr. Moser complains about, and who have to foot part of the bill.

 

Here we have an enduring paradox in a system of National Health. Insurance (a euphemism for socialized medicine do make the system sounded more palatable to Americans who have cut their teeth on the nostrum that “socialized” is a dirty word), the care is spread more evenly throughout the population but as it becomes expensive (health care is, after all, open ended) governments tend to ration health care. For example, most nations will gladly subsidize pediatric services because as babies grow older they require less and less care, and become increasingly independent of medical services. On the other hand (election speeches to the contrary) governments are increasingly aware that after a certain age the population becomes more dependent on medical services and uses them with greater frequency. Thus for the geriatric population medical care and medical costs spiral upwards. The government’s response is to seek ways of rationing medical care, and that is exactly what tends to occur in socialized systems.

In the process of distributing the beneficence of medical care more evenly than the free enterprise system bestows, socialized systems slow the rate at which this care can be dispensed. It is rationed.

 

Deprived of the incentives that propel the private sector the socialized sector system fails to provide for the exuberant innovative geysers that burst forth with important medical advances. The research arm of medicine subsidized but not controlled by government has been magnificent.

 

 

The pharmaceutical companies have provided important therapeutic modalities; and doctors in practice, because they have been able to see diseases from all sides by virtue of the plethora of instrumentation and chemistry that can be focused on a case, a patient or disease entity, incorporate this information into their collective experience. After a case is completed it is easy to look back and decide that only a small portion of the collected information was important. But if in one case in a thousand the extra tests reveal something unique, then roads are open for new categories or sub categories of disease (this is anecdotal stuff that no longer is acceptable).

 

Thus it is disappointing to read the Moser bewails the high cost of care, Medicine is a cauldron bubbling with facts and events. Cut back on the energy put into the process (the sop called wasted excess testing) and the boiling will stop and nothing will penetrate the flat calm. Nothing will surface to give us new insight. Moser and his restrictions impose a closed book. All is known, all progress is behind us.

 

Of course new stuff is good not bad. The CAT scan which frightened government because of the cost of each examination has already yielded benefits in human, scientific and economic terms that were unpredictable when the technique was introduced. We can look forward to non-invasive diagnostic technology and perhaps, as a result, to minimally invasive therapeutic technology. All bits of information are valuable even if not immediately useful.  Inventive technology, new machinery, exuberant testing may be bad economics but they are good medicine,